- Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease The Conversation
- Daily pill doubles survival time for pancreatic cancer patients BBC
- ‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long The Washington Post
- Daily pill can double survival time for world’s deadliest cancer, trial shows | Pancreas cancer The Guardian
- Standing ovation at ASCO 2026: Daraxonrasib Shines in Pancreatic Cancer Breakthrough Medical Dialogues